XLR11 N-(4-hydroxypentyl) metabolite (CRM)
- $117 - $228
- Product name: XLR11 N-(4-hydroxypentyl) metabolite (CRM)
- CAS: 1782099-36-8
- MF: C21H28FNO2
- MW: 345.45
- EINECS:
- MDL Number:
- Synonyms:XLR11 N-(4-hydroxypentyl) metabolite (CRM);[1-(5-fluoro-4-hydroxypentyl)indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone;XLR11 N-(4-hydroxypentyl) metabolite RM;4-Hydroxypentyl XLR11;XLR-11 4-hydroxypentyl metabolite;XLR11 N-(4-hydroxypentyl) metabolite;Methanone, [1-(5-fluoro-4-hydroxypentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-
2 prices
Selected condition:
Brand
- AK Scientific
- Cayman Chemical
Package
- 1mg
- ManufacturerAK Scientific
- Product number3857EB
- Product descriptionXLR11N-(4-hydroxypentyl)metabolite
- Packaging1mg
- Price$228
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number17727
- Product descriptionXLR11 N-(4-hydroxypentyl) metabolite (CRM)
- Packaging1mg
- Price$117
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 3857EB | XLR11N-(4-hydroxypentyl)metabolite | 1mg | $228 | 2021-12-16 | Buy |
Cayman Chemical | 17727 | XLR11 N-(4-hydroxypentyl) metabolite (CRM) | 1mg | $117 | 2024-03-01 | Buy |
Properties
Boiling point :490.0±40.0 °C(Predicted)
Density :1.14±0.1 g/cm3(Predicted)
pka :13.88±0.20(Predicted)
Density :1.14±0.1 g/cm3(Predicted)
pka :13.88±0.20(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|
Description
XLR11 is a synthetic cannabinoid (CB) featuring a tetramethylcyclopropyl group, which reportedly confers selectivity for the peripheral CB2 receptor over the central CB1 receptor. XLR11 also has an N-(5-fluoropentyl) chain, which increases binding to both CB receptors. XLR11 N-(4-hydroxypentyl) metabolite is an expected phase 1 metabolite of XLR11, based on the known metabolism of similar compounds. The physiological properties of this compound have not been evaluated. This product is intended for forensic and research applications.Cayman Chemical products containing Certified Reference Material (CRM) in the name are highly qualified materials manufactured and tested to meet ISO/IEC 17025:2005 and ISO Guide 34:2009 international guidelines for reference materials. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability to SI units of measure. Cayman’s CRMs are tested for Homogeneity and Stability and are provided with a certificate stating the CRM property value(s) along with the combined uncertainty of the property value(s). These materials are intended for quantitative applications where quantitative accuracy and uncertainty are critical. Cayman Chemical is committed to providing quality products to its customers as evidenced by its accreditation to the ISO/IEC 17025:2005 and ISO Guide 34:2009 standards. All traceable CRMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.More related product prices
XLR12 XLR11 N-(3-fluoropentyl) isomer XLR11 Degradant 1630022-98-8 1445578-20-0 XLR11 N-(2-fluoropentyl) isomerRelated product price
- XLR12
$81-802 - XLR11 N-(3-fluoropentyl) isomer
$70-440 - XLR11 Degradant
$115-775